These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7744111)

  • 1. Intraperitoneal chemotherapy with cisplatin and etoposide in ovarian carcinoma patients who are clinically in complete remission.
    Menczer J; Ben-Baruch G; Rizel S; Brenner H
    Eur J Gynaecol Oncol; 1995; 16(1):12-7. PubMed ID: 7744111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal cisplatin chemotherapy in ovarian carcinoma patients who are clinically in complete remission.
    Menczer J; Ben-Baruch G; Rizel S; Brenner H
    Gynecol Oncol; 1992 Aug; 46(2):222-5. PubMed ID: 1500025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer.
    Howell SB; Kirmani S; Lucas WE; Zimm S; Goel R; Kim S; Horton MC; McVey L; Morris J; Weiss RJ
    J Clin Oncol; 1990 Jan; 8(1):137-45. PubMed ID: 2295904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I-II study with intraperitoneal cisplatin plus systemic etoposide in patients with minimal residual ovarian cancer.
    Willemse PH; Sleijfer DT; de Vries EG; Boonstra H; Bouma J; Mulder NH
    Eur J Cancer; 1992; 28(2-3):479-81. PubMed ID: 1591067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer.
    Aziz Z; Zahid M; Ud Din Ahmed Z; Arshad T
    Aust N Z J Med; 1998 Jun; 28(3):403-9. PubMed ID: 9673759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
    Tournigand C; Louvet C; Molitor JL; Dehni N; Lejeune V; Sezeur A; Pigne A; Marpeau L; Cady J; de Gramont A
    Gynecol Oncol; 2001 Nov; 83(2):198-204. PubMed ID: 11606072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after second-look laparotomy.
    Menczer J; Ben-Baruch G; Modan M; Brenner H
    Cancer; 1989 Apr; 63(8):1509-13. PubMed ID: 2924259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of survival after second-line intraperitoneal cisplatin-based chemotherapy for advanced ovarian cancer.
    Piver MS; Recio FO; Baker TR; Driscoll D
    Cancer; 1994 Mar; 73(6):1693-8. PubMed ID: 7512437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after second look laparotomy. A reassessment based on mature data.
    Ben-Baruch G; Menczer J; Feldman B; Rizel S; Brenner H
    Eur J Gynaecol Oncol; 1994; 15(4):272-6. PubMed ID: 7957334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer.
    Malmström H; Rasmussen S; Simonsen E
    Gynecol Oncol; 1993 May; 49(2):166-71. PubMed ID: 8504983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission.
    Tournigand C; Louvet C; Molitor JL; Fritel X; Dehni N; Sezeur A; Pigné A; Cady J; Milliez J; de Gramont A
    Gynecol Oncol; 2003 Nov; 91(2):341-5. PubMed ID: 14599864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
    Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
    Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin, etoposide, and ifosfamide as second-line treatment for ovarian cancer.
    Fanning J; Hilgers RD; Hutson E
    Am J Clin Oncol; 1994 Aug; 17(4):335-7. PubMed ID: 8048396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma.
    Reichman B; Markman M; Hakes T; Hoskins W; Rubin S; Jones W; Almadrones L; Ochoa M; Chapman D; Saigo P
    J Clin Oncol; 1989 Sep; 7(9):1327-32. PubMed ID: 2671288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
    Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
    J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide.
    Colozza M; Mosconi AM; Gori S; Belsanti V; Basurto C; De Angelis V; Giansanti M; Tonato M
    Am J Clin Oncol; 1997 Oct; 20(5):522-6. PubMed ID: 9345342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer.
    Kirmani S; Braly PS; McClay EF; Saltzstein SL; Plaxe SC; Kim S; Cates C; Howell SB
    Gynecol Oncol; 1994 Sep; 54(3):338-44. PubMed ID: 8088611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer.
    Athanassiou AE; Bafaloukos D; Pectasides D; Dimitriadis M; Varthalitis I; Barbounis V
    Br J Cancer; 1989 Nov; 60(5):755-8. PubMed ID: 2803952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin plus VP 16-213 in advanced ovarian carcinoma.
    Harnett PR; Bell DR; Hillcoat BL; Woods RL; Levi JA; Rome RM; Campbell JC; Tattersall MH
    Gynecol Oncol; 1988 Jun; 30(2):159-62. PubMed ID: 3371739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin-containing versus cisplatin-free adjuvant chemotherapy in ovarian carcinoma. Results after second-look laparotomy.
    Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
    Oncology; 1990; 47(2):109-11. PubMed ID: 2314822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.